Posts in: May, 2019

Senate HELP Committee Releases Draft Legislation to Reduce Health Care Costs

On Thursday, May 23, Senators Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the chair and ranking Democrat of the Health, Education, Labor and Pensions (“HELP”)

31 May 2019

340B Annual Recertification For STD, TB and Title X Grantees In Process

The 340B annual recertification period for STD, TB and Title X  grantees started on May 13, 2019 and ends on June 10, 2019.  Recertification must

22 May 2019

May 9 House E&C Health Subcommittee hearing

On Thursday May 9, 2019 the House Energy and Commerce Committee, Health Subcommittee held a hearing on Lowering Prescription Drug Prices: Deconstructing the Drug Supply

14 May 2019

Final Rule Will Require Drug Manufacturers to Disclose Prices in TV Advertisements

Earlier today, HHS issued a Final Rule that will require pharmaceutical manufacturers to disclose the wholesale acquisition cost (“WAC”) in direct-to-consumer TV advertisements for all

8 May 2019

Court Holds 2019 Reimbursement Cuts for 340B Drugs Unlawful; Remands to HHS for Remedy for 2018 and 2019

On May 6, 2019, the U.S. District Court for the District of Columbia ruled that CMS acted outside its statutory authority in adopting an almost

6 May 2019

340B Ceiling Price Website Update – HRSA to Publish Additional Pricing Data Elements

The Office of Pharmacy Affairs (OPA) recently published an update regarding the 340B ceiling price website.  The update announces that HRSA will publish additional pricing

3 May 2019